Home  /  Resource Library  /  Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged >60 years with HL

Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged >60 years with HL

Keypoints – Brentuximab Vedotin plus dacarbazine is an active and well-tolerated combination for patients aged 60 years or older with hogkin lymphoma.